This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Thomas Specht: Innovating Eukaryotic Expression Systems
Introduction
Thomas Specht is an inventive mind from Kundl, Austria. With a unique contribution to the field of biotechnology, he holds a significant patent that revolutionizes eukaryotic cell expression systems. His work is instrumental in advancing genetic research and expression technology.
Latest Patents
Thomas Specht's prominent patent is titled "Constitutive yeast LLP promotor-based expression systems." This innovation provides a modified eukaryotic cell that lacks the SSN6-like protein, altering its functionality. The invention further includes a polynucleotide sequence comprising a modified ssn6-like gene and an expression vector. This vector is designed to facilitate gene expression in the absence of the SSN6-like protein. Additionally, the patent describes methods for assessing the purity of biological compositions and expressing targeted genes using the modified cells.
Career Highlights
Thomas Specht has made substantial strides in his career at Novartis AG, a leading global healthcare company. His expertise and innovative approach have placed him at the forefront of biotechnological advancements. The focus of his research and development is primarily on enhancing gene expression systems, contributing significantly to the pharmaceutical industry.
Collaborations
Throughout his career, Thomas has worked alongside distinguished colleagues such as Clemens Achmüller and Ferdinand Zepeck. These collaborations have fostered a collaborative environment where innovative ideas can flourish, further advancing the field of biotechnology.
Conclusion
Thomas Specht's contributions to the field of biotechnology, particularly through his innovative patent, showcase the importance of research and development in health and science. His work not only advances the understanding of gene expression in eukaryotic systems but also sets a benchmark for future innovations in the industry. As he continues to push boundaries in biotechnology, the impact of his inventions is expected to resonate across various applications in scientific research and medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile